TY  - RPRT
TI  - The i3+3 Design for Phase I Clinical Trials
AU  - Meizi Liu
AU  - Sue-Jane Wang
AU  - Yuan Ji
PY  - 2019
UR  - https://arxiv.org/abs/1901.01303
ID  - 1901.01303
ER  -